{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:03:57Z","timestamp":1790197437234,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jacig.2026.100771","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:13:40Z","timestamp":1786115620000},"page":"100771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Consistent adherence to biologic therapies is critical for improving outcomes in asthma"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0235-7105","authenticated-orcid":false,"given":"Njira L.","family":"Lugogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Modena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Kwiatek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyad","family":"Al-Lehebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vichiendilokkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvee","family":"Karsanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Hwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley","family":"Geason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijita","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Alfonso-Cristancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2026.100771_bib1","series-title":"Global strategy for asthma management and prevention","year":"2025"},{"key":"10.1016\/j.jacig.2026.100771_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.chest.2024.08.045","article-title":"Choosing the right biologic for the right patient with severe asthma","volume":"167","author":"Couillard","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.jacig.2026.100771_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0238-2023","article-title":"Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials","volume":"33","author":"Kyriakopoulos","year":"2024","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jacig.2026.100771_bib10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3109\/02770903.2016.1155217","article-title":"Enabling and hindering factors influencing adherence to asthma treatment among adolescents: a systematic literature review","volume":"53","author":"Ahmad","year":"2016","journal-title":"J Asthma"},{"key":"10.1016\/j.jacig.2026.100771_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41533-022-00281-z","article-title":"Medication availability and economic barriers to adherence in asthma and COPD patients in low-resource settings","volume":"32","author":"Tabyshova","year":"2022","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jacig.2026.100771_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/JAA.S328653","article-title":"Real world biologic use and switch patterns in severe asthma: data from the International Severe Asthma Registry and the US CHRONICLE study","volume":"15","author":"Menzies-Gow","year":"2022","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jacig.2026.100771_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.anai.2022.06.012","article-title":"Biologic use and outcomes among adults with severe asthma treated by US subspecialists","volume":"129","author":"Panettieri","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2026.100771_bib14","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1016\/j.jaip.2025.06.029","article-title":"Investigating the association between biologic initiation and medication adherence in severe asthma: an analysis of linked data","volume":"13","author":"Shackleford","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100771_bib15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jaip.2021.11.003","article-title":"The impact of adherence and health literacy on difficult-to-control asthma","volume":"10","author":"Zaeh","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100771_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12325-010-0093-7","article-title":"Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis","volume":"28","author":"Tan","year":"2011","journal-title":"Adv Ther"},{"key":"10.1016\/j.jacig.2026.100771_bib17","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2147\/PPA.S137206","article-title":"Impact of adherence to biological agents on health care resource utilization for patients over the age of 65 years with rheumatoid arthritis","volume":"11","author":"Lathia","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jacig.2026.100771_bib18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/rheumatology\/keu358","article-title":"Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort","volume":"54","author":"Bluett","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jacig.2026.100771_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jaip.2019.07.011","article-title":"Omalizumab treatment patterns among patients with asthma in the US Medicare population","volume":"8","author":"Li","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100771_bib20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.anai.2023.07.017","article-title":"Real-world severe asthma biologic administration and adherence differs by biologic: CHRONICLE study results","volume":"131","author":"Ledford","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2026.100771_bib21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.chest.2020.10.050","article-title":"Adherence to asthma biologics: implications for patient selection, step therapy, and outcomes","volume":"159","author":"Maddux","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jacig.2026.100771_bib22","article-title":"Real-world adherence to biologics and association with health outcomes in patients with asthma: a systematic literature review [abstract]","volume":"209","author":"Alfonso-Cristancho","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacig.2026.100771_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2147\/JAA.S522414","article-title":"The impact of biological therapies and the significance of their adherence on asthma outcomes in a single tertiary asthma center","volume":"18","author":"Al-Lehebi","year":"2025","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jacig.2026.100771_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1183\/09031936.00075614","article-title":"Medication adherence and the risk of severe asthma exacerbations: a systematic review","volume":"45","author":"Engelkes","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2026.100771_bib25","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.jaip.2023.12.049","article-title":"Cost-effectiveness and impact on health care utilization of interventions to improve medication adherence and outcomes in asthma and chronic obstructive pulmonary disease: a systematic literature review","volume":"12","author":"van Boven","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100771_bib26","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2147\/PPA.S209532","article-title":"New insights to improve treatment adherence in asthma and COPD","volume":"13","author":"George","year":"2019","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jacig.2026.100771_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40257-022-00683-2","article-title":"Long-term efficacy and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis: results through week 52 from a phase III open-label extension trial (LIBERTY AD PED-OLE)","volume":"23","author":"Blauvelt","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jacig.2026.100771_bib28","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jaip.2025.03.016","article-title":"Long-term efficacy and safety of benralizumab treatment for PDGFRA-negative hypereosinophilic syndrome","volume":"13","author":"Kuang","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100771_bib29","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1007\/s12325-019-01037-x","article-title":"Retrospective claims analysis indirectly comparing medication adherence and persistence between intravenous biologics and oral small-molecule therapies in inflammatory bowel diseases","volume":"36","author":"Moran","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/j.jacig.2026.100771_bib30","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2147\/JAA.S363217","article-title":"Impact of the COVID-19 pandemic on incidence of asthma exacerbations and hospitalizations in US subspecialist-treated patients with severe asthma: results from the CHRONICLE study","volume":"15","author":"Moore","year":"2022","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jacig.2026.100771_bib31","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A7147","article-title":"Real-world persistence to biologic therapies and its impact on outcomes in patients with asthma [abstract]","volume":"211","author":"Kwiatek","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacig.2026.100771_bib32","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.3390\/jcm14093153","article-title":"Biologic therapies for severe asthma: current insights and future directions","volume":"14","author":"Faria","year":"2025","journal-title":"J Clin Med"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829326001335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829326001335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:29:26Z","timestamp":1790195366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829326001335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2772829326001335"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2026.100771","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consistent adherence to biologic therapies is critical for improving outcomes in asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2026.100771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100771"}}